Read + Share
Hampel PJ, Rabe KG, Call TG, Ding W, et al. Combined ibrutinib and venetoclax for treatment of patients with
ibrutinib-resistant or double-refractory chronic lymphocytic leukaemia. Br J Haematol 2022;199:239-244.
PMID: 35841338
|
 |
|
Hampel PJ, Rabe KG, Call TG, Ding W, et al. Combined ibrutinib and venetoclax for treatment of patients with
ibrutinib-resistant or double-refractory chronic lymphocytic leukaemia. Br J Haematol 2022;199:239-244.
PMID: 35841338
|
|
|
|